Jump to Content Jump to Main Navigation
HOME BROWSE
CLINICAL RESOURCES DRUG INFORMATION EDUCATION AND TRAINING PHARMACY PRACTICE CAREER DEVELOPMENT
AJHP DRUG INFORMATION PROFESSIONAL DEVELOPMENT
Sign in Sign up
Advanced Search Help
Sign in Sign up
HOME BROWSE
CLINICAL RESOURCES DRUG INFORMATION EDUCATION AND TRAINING PHARMACY PRACTICE CAREER DEVELOPMENT
AJHP DRUG INFORMATION PROFESSIONAL DEVELOPMENT
Advanced Search Help

Cover Competence Assessment for Compounding Hazardous Drugs eReport
 

 

  • Front Matter
    • Preliminary Material
    • Learning Objectives
    • Overview
    • Definition of a Hazardous Drug
    • Precautions
  • Facility Design
    • Facilities for Storing and Compounding Hazardous Drugs
    • Other Attributes of Facilities for Compounding Hazardous Drugs
    • Requirements for Compounding Nonsterile Hazardous Drugs
    • Requirements for Compounding Sterile Hazardous Drugs
    • Figure 1: Recommendations for Compounding and Handling Noninjectable Hazardous Drug Dosage Forms
  • Aseptic Technique
    • Figure 2: Recommendations for Use of Class II BSCs
    • Figure 3: Recommendations for Use of Class III BSCs and Compounding Isolators
    • Figure 4: Recommendations for Use of Gloves
    • Eye Protection and Respirators
  • Work Practices
    • Compounding Procedures
    • Decontaminating, Deactivating Substances, and Cleaning the Work Area
    • Figure 5: Recommendations for Use of Gowns
    • Figure 6: Recommendations for Working in BSCs and Compounding Isolators
    • Spills
    • Direct Skin or Eye Contact
    • Disposal
  • Medical Surveillance Program
    • Figure 7. Recommended Contents of Hazardous Drug Spill Kit
    • Figure 8. Recommendations for Spill Cleanup Procedure
    • Figure 9. OSHA-Recommended Steps for Immediate Treatment of Workers with Direct Skin or Eye Contact with Hazardous Drugs
    • References
    • Resources
    • Competence Checklist
    • Competency Assessment Exam
    • Answer Key

Compounding Procedures

in Competence Assessment for Compounding Hazardous Drugs eReport
Editor:
Patricia C. Kienle
DOI:
https://doi.org/10.37573/9781585285945.014
Restricted access
Email this content

Share Link


Copy this link, or click below to email it to a friend
Email this content
or copy the link directly:
The link was not copied. Your current browser may not support copying via this button.
Link copied successfully

About ASHP Contact Us Correction Notices Customer Relations
FAQs Information for Authors Libraries and Institutions Rights and Permissions

© 2023 American Society of Health-System Pharmacists. All Rights Reserved.

Powered by: PubFactory

Powered by PubFactory
  • [3.235.173.24]
  • 3.235.173.24
Close
Edit

Character limit 500/500

@!

Character limit 500/500